Overexpression of SMOC 2 Attenuates the Tumorigenicity of Hepatocellular Carcinoma Cells and Is Associated With a Positive Postoperative Prognosis in Human Hepatocellular Carcinoma

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of Cancer Related Genes Using a Comprehensive Map of Human Gene Expression

  2016cited by this paper
• Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression

  2016cited by this paper
• JunB promotes cell invasion, migration and distant metastasis of head and neck squamous cell carcinoma

  2016cited by this paper
• Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study

  2016cited by this paper
• An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-Sufficiency.

  2016cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma

  2015cited by this paper
• RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• SIBLINGs and SPARC families: their emerging roles in pancreatic cancer.

  2014cited by this paper
• Modulation of stemness in a human normal intestinal epithelial crypt cell line by activation of the WNT signaling pathway.

  2014cited by this paper
• Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.

  2014cited by this paper
• Matricellular proteins: multifaceted extracellular regulators in tumor dormancy

  2014cited by this paper
• Lymphovascular invasion and histologic grade are associated with specific genomic profiles in invasive carcinomas of the breast

  2014cited by this paper
• Revisiting the matricellular concept

  2014cited by this paper
• MicroRNA-Regulated Protein-Protein Interaction Networks and Their Functions in Breast Cancer

  2013cited by this paper
• SPARCL1 suppresses metastasis in prostate cancer

  2013cited by this paper
• Effect of GINS2 on Proliferation and Apoptosis in Leukemic Cell Line

  2013cited by this paper
• Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis

  2013cited by this paper
• EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

  2012cited by this paper
• Matricellular Proteins: A Sticky Affair with Cancers

  2012cited by this paper
• Epidemiology of viral hepatitis and hepatocellular carcinoma.

  2012cited by this paper
• Risk Factors, Prognosis, and Management of Early and Late Intrahepatic Recurrence After Resection of Primary Clear Cell Carcinoma of the Liver

  2011cited by this paper
• Homozygosity mapping and candidate prioritization identify mutations, missed by whole-exome sequencing, in SMOC2, causing major dental developmental defects.

  2011cited by this paper
• Genome-Wide Analysis of Promoter Methylation Associated with Gene Expression Profile in Pancreatic Adenocarcinoma

  2011cited by this paper
• Microgenomics of Ameloblastoma

  2011cited by this paper
• Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells

  2009cited by this paper
• The developmentally-regulated Smoc2 gene is repressed by Aryl-hydrocarbon receptor (Ahr) signaling.

  2009cited by this paper
• Developmental expression of Smoc1 and Smoc2 suggests potential roles in fetal gonad and reproductive tract differentiation

  2009cited by this paper
• EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.

  2008cited by this paper
• The widely expressed extracellular matrix protein SMOC-2 promotes keratinocyte attachment and migration.

  2008cited by this paper
• The SPARC-related factor SMOC-2 promotes growth factor-induced cyclin D1 expression and DNA synthesis via integrin-linked kinase.

  2008cited by this paper
• Identification of candidate methylation-responsive genes in ovarian cancer

  2007cited by this paper
• RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer

  2007cited by this paper
• Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors.

  2006cited by this paper
• The Novel SPARC Family Member SMOC-2 Potentiates Angiogenic Growth Factor Activity*

  2006cited by this paper
• Beyond the Bench: Tracking Clues with Environmental Health Sleuths

  2006cited by this paper
• Tumor and metastasis suppression by the human RNASET2 gene.

  2005cited by this paper
• Hepatocellular carcinoma: the need for progress.

  2005cited by this paper
• Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.

  2005cited by this paper
• Hevin/SC1, a matricellular glycoprotein and potential tumor-suppressor of the SPARC/BM-40/Osteonectin family.

  2004cited by this paper
• High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.

  2004cited by this paper
• Characterization of SMOC-2, a modular extracellular calcium-binding protein.

  2003cited by this paper
• Targeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene ontology analysis

  2003cited by this paper
• Identification of candidate tumor‐suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms

  2003cited by this paper
• Apoptosis-targeted therapies for cancer.

  2003cited by this paper
• Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

  2001cited by this paper
• Screening for hepatocellular carcinoma in patients with advanced cirrhosis

  1999cited by this paper
• Cancer statistics

  1989cited by this paper

• Common Molecular Alterations in Canine Oligodendroglioma and Human Malignant Gliomas and Potential Novel Therapeutic Targets

  2019cites this paper
• Secreted modular calcium-binding proteins in pathophysiological processes and embryonic development

  2019cites this paper